I took the time to look at a number of biotech companies focusing strictly on cancer research. Unless I am missing something the cancer research portion of the company alone should be worth over $1.50 /share.
Definitely the Rodney Dangerfield of the industry. NO RESPECT!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.